chrisvoncsefalvay/vaers-outcomes huggingface dataset:
Paresthesia of upper and lower limbs which is exacerbated by sitting or lying.  Symptoms are worse at night causing sleeplessness.
body aches; This is a spontaneous report from a contactable consumer (patient) from a Pfizer sponsored program. The female patient received bnt162b2 (BNT162B2), dose 1 via an unspecified route of administration on 10Apr2021 (Batch/Lot number was not reported) as SINGLE DOSE for covid-19 immunisation. The patient medical history and concomitant medications were not reported. The patient experienced body aches on an unspecified date. The patient  wanted to know if she can take tylenol or advil for it. The outcome of the event was unknown.  No follow-up attempts are needed; information about lot/batch number cannot be obtained.
Fever the evening after receiving vaccines. Parents gave TYLENOL. The infant was sleeping-then at 4:30 AM, the child cried out, then stiff and unresponsive; mother brought directly to ER. She was pale and pulseless upon arrival. Multiple rounds of CPR/epinephrine/atropine. Brief returns of sinus bradycardia. CPR discontinued at 07:19.
I started feeling a little sick. I had sniffy and coughing. My throat started to hurt. I didn't have a fever. About 3 weeks later, my cough became worse. I did a COVID-19 test, which it was negative. Another 2 weeks still coughing. New years eve I could not get out of bed. My chest begin to hurt and could not breathe. I was about to go to bed and my head started hurting. My whole side of my body became numb. I received an MRI and they found a small socket in my brain.
Skin reaction at injection site initial evening growing to 3 x 2 inches over next day, itching, headache severe for first day then slowly abating, shakiness, fatigue. These were not observed when pt got first shot in December-only after 2nd shot in March.
I tested positive for COVID-19 on 5/20/23. I had sore throat, chills, and a cough. I contacted my doctor and was prescribed Paxlovid. My symptoms went away fast except my cough, it lingered for about 2 weeks.
Up and down heat flashes; Extremely hyper; chills; Fatigueness or wearing down; This spontaneous case was reported by a consumer and describes the occurrence of HOT FLUSH (Up and down heat flashes), FEELING ABNORMAL (Extremely hyper), CHILLS (chills) and FATIGUE (Fatigueness or wearing down) in a 44-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 038A21A) for COVID-19 vaccination.     Concurrent medical conditions included Seasonal allergy, Psoriatic arthritis and Chronic migraine.    On 19-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 19-Mar-2021, the patient experienced HOT FLUSH (Up and down heat flashes), FEELING ABNORMAL (Extremely hyper), CHILLS (chills) and FATIGUE (Fatigueness or wearing down). At the time of the report, HOT FLUSH (Up and down heat flashes), FEELING ABNORMAL (Extremely hyper), CHILLS (chills) and FATIGUE (Fatigueness or wearing down) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No concomitant medication was reported. No treatment medication was reported. It was reported that the patient took second dose of Moderna vaccine on 16-APR-2021 on the right arm and the batch no was reported to be 031B21A
have all these side effects: pain at the injection site; have all these side effects: swelling at the injection site; have all these side effects: redness at the injection site; have all these side effects: muscle pain; have all these side effects: tiredness; have all these side effects: shivering; have all these side effects: headache; have all these side effects: fever; have all these side effects: upset stomach; This case was reported by a consumer via interactive digital media and described the occurrence of injection site pain in a patient who received Herpes zoster (Shingrix) for prophylaxis.   On 27th April 2022, the patient received the 2nd dose of Shingrix. In April 2022, less than a day after receiving Shingrix, the patient experienced injection site pain, injection site swelling, injection site erythema, muscle pain, tiredness, shivering, headache, fever and upset stomach. On an unknown date, the outcome of the injection site pain, injection site swelling, injection site erythema, muscle pain, tiredness, shivering, headache, fever and upset stomach were unknown.   It was unknown if the reporter considered the injection site pain, injection site swelling, injection site erythema, muscle pain, tiredness, shivering, headache, fever and upset stomach to be related to Shingrix.   Additional Information: GSK Receipt Date: 28-APR-2022 Reporter's Comment: This case was reported by a consumer via interactive digital media. The patient had Shingrix vaccine last night. The patient had all these common side effects were pain, redness , swelling at injection site, muscle pain, tiredness, headache, fever, shivering, upset stomach. Additional Supportive Information: The follow up would not possible as no contact details were available.
PATIENT STATES THAT APPROXIMATELY 1 WEEK AFTER HE RECEIVED THE SHINGRIX VACCINATION, HE BEGAN HAVING ACHES AND PAINS IN HIS RIGHT ARM (SAME ARM THAT HE RECEIVED HIS SHOT IN).  HE SAID THAT HE SOMETIMES HAS TINGLING IN HIS ARM AS WELL.  THE PAIN TRAVELS FROM HIS ELBOW TO HIS SHOULDER, AND TO HIS WRIST.  HE SAID THAT ONE DAY THE PAIN MAY BE WORSE IN HIS ELBOW, AND THE NEXT IT MAY BE WORSE IN HIS WRIST.  HE STATES THAT HE DOES NOT HAVE CONSTANT PAIN, THAT IT COMES AND GOES.  THE PAIN IS ONLY IN HIS RIGHT ARM.  HE IS NOT EXPERIENCING ANY OTHER SYMPTOMS.  HE WENT TO THE URGENT CARE ON 9/28/22, AND THEY GOT AN X-RAY, AND SENT HIS FOR AN ULTRASOUND.  HE ALSO SAW AN ORTHOPEDIC PHYSICAN, AND THEY CAN NOT DETERMINE WHAT IS WRONG.  HE IS GOING TO FOLLOW UP WITH HIS PRIMARY CARE PHYSICAN NEXT WEEK.
arm pain; exacerbated with movement; This case was reported by a consumer via call center representative and described the occurrence of pain in arm in a 78-year-old male patient who received Herpes zoster (Shingrix) for prophylaxis.   Previously administered products included Shingrix (1st dose received on an unknown date).   On 19th June 2020, the patient received the 2nd dose of Shingrix. On 20th June 2020, 1 days after receiving Shingrix, the patient experienced pain in arm and injected limb mobility decreased. On an unknown date, the outcome of the pain in arm was not recovered/not resolved and the outcome of the injected limb mobility decreased was unknown.   It was unknown if the reporter considered the pain in arm and injected limb mobility decreased to be related to Shingrix.  Additional details were provided as follows: The reporter stated that there were no events associated with 1st dose of Shingrix. The patient received the 2nd dose Shingrix in left deltoid, he experienced left arm pain. The patient reports that to this day, the arm pain was still there and was exacerbated with movement The reporter consented to follow up. No further information was available.
Information has been received from a health professional concerning a pt who was vaccinated in 1986, 1995 and 2000 with MMR II. Subsequently, the pt tests are negative. The pt "calls herself an MMR nonconverter." Additional info has been requested.
Got my shot at 10 am. Then about 4 am the next morning I woke up with my arm swollen, about the size of credit card, hard and hot. Then I guess it was about 11 am I started to feel week. Then by 12 noon, I started aching all over. As the day went on the aches got worse and I started developing chills. By 4 pm I had a fever of 102. The fever is still with me and it is currently 1030 am on Saturday April 10. I am very dizzy and not feeling myself. I woke up in a lake of sweat sometime throughout the night and had to change sheets and shower.  The chills and body ache are still here, and my arm is still sore and red and hot.
Within 12 hours or so the following effects were noted.  This was the first injection. 1. Injection site soreness/tenderness for up to 3 days. 2. General sore joints throughout my body. 3. Intense and long headache that lasted for up to 36 hours until Acetaminophen was final taken.  The headache continued for another day or so at a lower intensity. 4. Fever up to 101 F and chills for up to 1.5 days. 5. General feeling of lack of concentration and being "hazy" in general condition.  As of 4/20/2021 most effects have subsided.  General treatment for discomfort was Acetaminophen after 36 hours from the injection date and time.  The injection site is still sore but no mark or rash exists.
Doesn't seem serious, but one week after the shot I have developed a large, itchy red spot at the site of the injection
Interchange of Vaccine/not carry Twinrix at low cost, so they administered a dose of Havrix and Engerix-B on 12Jul2023; This non-serious case was reported by a nurse via call center representative and described the occurrence of interchange of vaccine products in a 43-year-old female patient who received HAV (Havrix) (batch number 772YT, expiry date 23-SEP-2025) for prophylaxis.   Co-suspect products included HBV (Engerix B) (batch number 79S54, expiry date 04-APR-2025) for prophylaxis.   Previously administered products included Twinrix (1st dose received on 16th January 2020 with batch number 53AT5).   On 12-JUL-2023, the patient received Havrix and Engerix B. On 12-JUL-2023, an unknown time after receiving Havrix and Engerix B, the patient experienced interchange of vaccine products (Verbatim: Interchange of Vaccine/not carry Twinrix at low cost, so they administered a dose of Havrix and Engerix-B on 12Jul2023). The outcome of the interchange of vaccine products was unknown.   This report is made without prejudice and does not imply any admission or liability for the incident or its consequences.   Additional Information: Receipt date: 03-AUG-2023 The nurse reported a patient received one dose of Twinrix at a different facility and patient then came in to health department, who did not carry Twinrix at low cost, so they administered a dose of Havrix and Engerix-B. At the time of reporting, no further dosing had been administered. The vaccine administration facility was the same as primary reporter. The reporter consented to follow up.  The patient received Twinrix and then Engerix-B and Havrix, which led to interchange of vaccine products.
Swelling of the lips and cheek area.  Major and rapid drop in blood pressure.  Chills and slight fever
Inbound call from customer to provide updated temperature excursion information. She also provided names and administration dates of improperly stored administered ROTATEQ that was not supported. See original AE case 02429442 which did not include un; This spontaneous report was received from Other and refers to a patien of unknown gender and age.  The patient's medical history was not reported. The patient's concurrent conditions were not reported. Concomitant therapies were not reported.  On 12-JUL-2023, the patient started therapy with rotavirus vaccine, live, oral, pentavalent (ROTATEQ) oral liquid, 2 ml, lot #1968385, expiration date: 22-MAY-2024, administered for prophylaxis (strength, and route of administration were not provided).  On 12-JUL-2023, the patient experienced Inbound call from customer to provide updated temperature excursion information. She also provided names and administration dates of improperly stored administered ROTATEQ that was not supported. Temperature excursion: 20-JUN-2023 - 34.9F for 6 hours 34 minutes 0 seconds, 03-JUL-2023 - 51.4 F for 7 hours 33 minutes 0 seconds, 04-JUL-2023 - 51.1F for 24 hours 0 minutes 0 seconds and 05-JUL-2023 - 50.7F for 9 hours 27 minutes 0 seconds.See original AE case 02429442 which did not include unique patient identifiers. Company awareness date reflects the date was originally made aware. Additional AE cases were created for all patients involved: 02430210 02430211 02430254 02430255 02430256 02430257 02430258 02430259 02430261 02430267 02430578 02430599 02430623 02430642 02430682 02430683 02430684 02430686 02430687 02430690 02430691 02430699 02430701. No PQC. No additional information.
Systemic: see details-Moderate, Additional Details: patient called our pharmacy expressing frustration and anger regarding his prolonged side effects post-covid19 vaccination. patient generally explained that since receiving his vaccination, his skin has been "weird" and went on to describe that he has had "inflammation of the brain, digestive issues, heart issues, lung issues, liver issues, and chest pain." patient explained that his nurses and doctor(s) have asked him if he received covid19 vaccine. difficulty sleeping and walking
My second dose (1st was 1/21/21). was 2/25/21   No reaction except locally and fatigue.  Arrhythmia diagnosed by pulmonologist  4/2 taking my hands and then confirmed by 2 EKGs.   Never had any kind of heart issue.  AM asymptomatic except perhaps shortness of breath.  Currently wearing monitor and had echocardiogram this morning.
Dizziness; Chills; This spontaneous case was reported by a patient family member or friend and describes the occurrence of DIZZINESS (Dizziness) and CHILLS (Chills) in an elderly female patient who received mRNA-1273 (Spikevax) for COVID-19 prophylaxis.     No Medical History information was reported.    On an unknown date, the patient received dose of mRNA-1273 (Spikevax) (unknown route) 1 dosage form. On an unknown date, the patient experienced DIZZINESS (Dizziness) and CHILLS (Chills). At the time of the report, DIZZINESS (Dizziness) and CHILLS (Chills) outcome was unknown.        The action taken with mRNA-1273 (Spikevax) (Unknown) was unknown.   For mRNA-1273 (Spikevax) (Unknown), the reporter did not provide any causality assessments.   No concomitant product was reported. No treatment information was reported.   This case was linked to MOD-2023-708885 (Patient Link).
A few hours after getting the vaccine, my arm became sore. It got worse as the night went on. It was extremely achy. It was still happening as of Saturday, I also felt lightheaded. I felt like a was on a merry-go-round, it felt like it kept getting faster and faster. I felt dizzy all day Saturday. I had to rest all day. I lost my appetite. Anytime I got up to go to the bathroom, I had to hold something to walk. I also had a mild headache. I felt better on Sunday.  My arm was still a little sore as of yesterday but it is better today.
pt recvd vax;started screaming at 1pm till 3:45pm;would dose but if put down would scream again;8pm fell asleep & slept all noc;MD was called but did not see pt;
This spontaneous report as received from a pharmacist refers to a 82 year old female patient. The pharmacist reported that about 5 years ago, assumed in 2009, the patient was given the VARIVAX (Merck) (subcutaneous, 0.5 ml) in error. She was supposed to have gotten ZOSTAVAX. No adverse effects reported. Additional information has been requested.
On 03/31/2023 in the morning I had fever, chills, muscles aches, headaches, and high blood sugar for 6 weeks. After having COVID-19 I have brain fog, chills, and head aches. I am more forgetful now. I took 2 home tests on 04/01/2023. I tested negative after 7 days. I took 2 PCR test. First test was inconclusive on 04/16/2023. The second PCR follow up 04/17/2023 which was positive.
Information has been received from a physician referring to multiple unspecified patients of unknown age and gender. The patients' medical history, concurrent condition and concomitant medication were not reported. On unknown dates, the patients were vaccinated with improperly stored GARDASIL 9 (lot # reported as M036301 with expiration date 20-DEC-2017; lot# M013636 with expiration date 15-MAR-2018; lot# L036301 with expiration date 20-DEC-2017, dose and route were not reported). The vaccine had been stored under the temperature of 34 Fahrenheit degrees for 72 hours and 35 Fahrenheit degrees for 72 hours. A data logger was used to log the temperatures. No adverse effects were reported. Lot number M036301 is an invalid lot number for hpv rl1 6 11 16 18 31 33 45 52 58 vlp vaccine (yeast). This is one of the several reports received from the same reporter. Additional information has been requested.
Dizziness after 10 minutes lasting a few minutes, on the way home after 30 minutes wait experienced lips became numb, dizziness, diarrhea and metal taste. A few days later on 7/10 nose and roof of mouth became numb and didn?t feel well.  On 7/14 experience numbness in face and roof of mouth, dizziness and head ache
The pt experienced right upper arm redness, swelling and warmth to the touch from shoulder to elbow per physicians report.
Information has been received from a nurse concerning a 16 year old female who on approximately 01-AUG-2007, was vaccinated with Gardasil.  On approximately 01-AUG-2007, after she received her first dose, the patient fainted.  On 10-AUG-2007, the patient recovered.  Additional information has been requested. This is in follow-up to report(s) previously submitted on 9/17/2007. Information has been received from a licensed practical nurse concerning a 16 year old female patient with a phobia of needles, an anxiety disorder and panic attacks and a history of dysmenorrhea and fainting with injections, who on 01-AUG-2007, was vaccinated IM into the left deltoid with a first 0.5ml dose of GARDASIL (Lot# 657736/0389U). Concomitant therapy included LEXAPRO and ATIVAN, NEXIUM, SEASONIQUE and ZYRTEC. After she received the vaccine, the patient fainted in the hallway. It was reported that the "patient came to on her own after 5 seconds." She sat in the hallway for a while then laid down on the exam table for 5 minutes. The patient was reported as having more color and doing better. The nurse and the patient's mother walked her to the car to leave. It was also reported that the patient had stated prior to injection that she does not do well with needles, usually faints. At the time of this report, the patient recovered. It was reported that the patient will receive a 2nd dose in 2 months and with the next injection the patient should sit for about 15 minutes after the injection. No product quality complaint was involved. Additional information is not expected.
55 y.o. female with a lifetime history of insulin-dependent diabetes that presented to the emergency room just a few hours after she started having a left-sided neurologic deficit.  The patient reports that she had a stroke several years ago but for some reason was told to not take aspirin and was not started on Plavix.  Irregardless, the patient came in with a very significant left-sided neurologic deficit.  She states that she could not speak, she had left facial droop, left arm weakness, and left leg weakness.  She initially had an NIH stroke scale in the emergency room of 11.  Initial CT of the head showed nothing acute.  Consultation with neurology was obtained and the patient was sent for a CTA of the head and neck.  No large vessel occlusion was identified and shortly after this the patient's NIH stroke scale reduced to 2 and shortly after this the neurologic deficit completely resolved and stroke scale return to 0.  At that point, the patient was diagnosed with a TIA and admitted to the hospital for observation.  This morning she states she feels fine.  She has no neurologic deficit whatsoever.  She denies any sensory or strength deficits this morning at all.  The patient sugars have been a little bit high, but otherwise she had an uneventful evening
Approx 4-5 DTP/OPV/HIB pt found to be cyanotic in crib; was breathing moving but quiet; taken to ER by rescue 02 given in transit; t38.5; observed 2 days in hosp; minor URI, viral-like exanthem; pallor
Patient received immunizations on 01/29/01, one day after the patient developed swelling, redness, and pain at the injection site (left deltoid).
On 08APR2022 I experienced shortnees of breath while bending over and had repeated episodes of shortness of breath and diffuculty performing normal tasks including walking normal distaneces.  I had a complete cardiac and pulmonary workup no reason could be found for the shortness of breath.  Pulmonologists ordered Pulmonary tests and CT scans.  Function diminished and not improved with Albuterol or Symdicort.  CT scan shows infiltrate and micro nodules these come and go with scans.  Pulmonolgists thinks that it is due to secretions getting into lungs from my conditions of Gird and RHI.  Shortness of breath is ongoing on a daily basis despite attempts to diminish secretions.
32mins post vaccination pt c/o mild scratchy troat and shakiness. Vitals: @16:50 BP 140/86, HR 60, RR 18, O2 Sat 99% breath sounds clear-- > @16:58 156/84, 64, 18, 100%.  Pt stable and released from the vaccination site w/ daughter driving.  ER precautions given.
The pt received varicella vaccine on 7/18/97. Presents to clinic on 1/30/02 with rash appearing to be shingles. Probably recovered but unknown.
The patient rapidly developed respiratory failure and oxygen desaturation days after vaccination. Transferred to hospital. Per F/U on 6/25/02: immediate cause of death; respiratory failure and pneumonia.
Other than the expected sore arm at injection site, I?ve been experiencing slight chest pain. It feels like something is sitting on my chest or stuck inside of my chest. This began early Sunday morning around 1:00am.
Dizziness (12:30pm),  numbness in tongue (2pm), redness/swelling of right ear (2:30pm), wheezing (3:30pm)
Mother called and stated that patient was experiencing a flushed face, body aches, and swollen hands.  Mother denied difficulty breathing, rash, or hives.
Vaccinated on 4/24/01, on 4/7/01 developed Urticarial rash with lesions resembling erythema multiforme on 4/28/01. Treated with steroids antihistamines, eventually seen in ER/ID consult and referred to allergist.
This spontaneous report as received from a certified medical assistant (C.M.A.) refers to a patient of unknown age and gender. On 20-SEP-2016, the patient was vaccinated with a expired dose ZOSTAVAX with lot # L021609 and expiration date 10-SEP-2016; 0.65 ml, via subcutaneous route. No adverse effects reported. No product quality complaint was involved. No further information was provided. Additional information has been requested.
Headache; muscle aches; low grade fever; fatigue; This is a spontaneous report from a contactable other HCP (patient). A 30-year-old female (non-pregnant) patient received second dose of BNT162B2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Formulation: Solution for injection, Lot number: EL9264, Expiration Date: not reported) via intramuscularly in left arm on 03Feb2021 11:45 (at the age of 30-years-old) as 2nd dose, single dose for COVID-19 immunization. The patient historic vaccine included first dose of the BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, solution for injection, Lot Number EL1283, Expiration Date: unknown), via Intramuscularly in left arm on 12Jan2021 05:00 PM at 1st dose, single dose for COVID-19 immunization. The patient did not received any other vaccines within 4 weeks prior to the COVID vaccine. The patient medical history was not reported. Concomitant medications included other medications the patient received within 2 weeks of vaccination of Effexor 75 mg, Magnesium 50 mg, Iron 50 mg. On 03Feb2021 at 15:00, the patient experienced headache, muscle aches, low grade fever, fatigue. Prior and post to vaccination, the patient was not diagnosed with COVID-19. Treatment was not received for the adverse events. The outcome of the events was reported as recovering.  Follow-up attempts are completed. No further information is expected.
Information has been received from a registered nurse, who reported that multiple unspecified patients (demographics unknown) received LIQUID PEDVAXHIB (dosages, routes of administration, lot numbers and expiration dates not provided) on multiple unspecified days, which had been improperly stored. No adverse effect reported. No additional information available. Additional information has been requested.
swelling, soreness, red rash, itchiness that developed day after shot and continued for 5 days. Took Tylenol day after and applied OTC cortisone cream the days following.